The ECG-DiaNet model, integrating ECG features with clinical risk factors, significantly improved incident Type 2 diabetes prediction compared to clinical risk factors alone (AUROC 0.845 vs 0.8217).
Cohort (n=2,438)
Does integrating ECG features with clinical risk factors using a deep learning model improve the prediction of incident T2DM compared to clinical risk factors alone?
A multimodal deep learning model combining ECG features and clinical risk factors significantly improves the prediction of incident Type 2 Diabetes Mellitus.
Absolute Event Rate: 0.845% vs 0.8217%
p-value: p=<0.001
Type 2 Diabetes Mellitus (T2DM) remains a significant global health challenge, underscoring the need for early and accurate risk prediction tools to enable timely interventions. This study introduces ECG-DiaNet, a multimodal deep learning model that integrates electrocardiogram (ECG) features with established clinical risk factors (CRFs) to improve the prediction of T2DM onset. Using data from the Qatar Biobank (QBB), we compared ECG-DiaNet against unimodal models based solely on ECG or CRFs. A development cohort (n = 2043) was utilized for model training and internal validation, while a separate longitudinal cohort (n = 395) with a median five-year follow-up served as the test set. ECG-DiaNet demonstrated superior predictive performance, achieving a higher area under the receiver operating characteristic curve (AUROC) compared to the CRF-only model (0.845vs.0.8217), which was statistically significant based on the DeLong test (p < 0.001), thus highlighting the added predictive value of incorporating ECG signals. Reclassification metrics reinforced these improvements, with a significant Net Reclassification Improvement (NRI = 0.0153,p < 0.001) and Integrated Discrimination Improvement (IDI = 0.0482,p = 0.0099), confirming the enhanced risk stratification. Furthermore, stratifying participants into Low-, Medium-, and High-risk categories revealed that ECG-DiaNet achieved a higher positive predictive value (PPV) in the high-risk group compared to CRF-only models. These findings, together with the non-invasive nature and wide accessibility of ECG technology, suggest the potential of ECG-DiaNet for clinical implementation. However, further validation using larger and more diverse datasets is needed to improve generalizability.
Mohsen et al. (Fri,) conducted a cohort in Type 2 Diabetes Mellitus (n=2,438). ECG-DiaNet (ECG features + Clinical Risk Factors) vs. Clinical Risk Factors (CRF)-only model was evaluated on AUROC for incident T2DM prediction (95% CI 0.8427-0.8451, p=<0.001). The ECG-DiaNet model, integrating ECG features with clinical risk factors, significantly improved incident Type 2 diabetes prediction compared to clinical risk factors alone (AUROC 0.845 vs 0.8217).